Clinical Trials on Osteochondrodysplasias in Poland
Total 18 results
-
National Institute of Geriatrics, Rheumatology...Medical Research Agency, PolandRecruiting
-
Warner ChilcottCompletedOsteogenesis ImperfectaChile, United States, Spain, Australia, Belgium, United Kingdom, Czech Republic, Finland, Germany, Hungary, Italy, Poland, South Africa
-
Baylor College of MedicineOregon Health and Science University; Genzyme, a Sanofi CompanyCompletedOsteogenesis ImperfectaUnited States
-
Oregon Health and Science UniversityEli Lilly and Company; National Institutes of Health (NIH); National Center for... and other collaboratorsCompletedOsteogenesis ImperfectaUnited States
-
Baylor College of MedicineUniversity of Washington; Shriners Hospitals for Children; University of NebraskaActive, not recruiting
-
Oregon Health and Science UniversityUniversity of Utah; BioMarin PharmaceuticalCompleted
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedOsteogenesis ImperfectaUnited States
-
Ultragenyx Pharmaceutical IncActive, not recruitingOsteogenesis ImperfectaUnited States, Italy, Brazil, France, Canada, Germany, Netherlands, Poland
-
AmgenTerminatedOsteogenesis Imperfecta (OI)Canada, Czechia, Spain, United Kingdom, United States, Italy, Hungary, Australia, Belgium, France, Germany, Poland
-
AmgenRecruitingOsteogenesis ImperfectaUnited States, United Kingdom, Turkey, Hungary, Germany, Switzerland, Spain, Japan, France, Belgium, Poland, Australia, Austria, Slovakia, Canada
-
Ultragenyx Pharmaceutical IncMereo BioPharmaActive, not recruitingOsteogenesis ImperfectaUnited States, Turkey, Germany, United Kingdom, Italy, Portugal, Canada, Australia, Argentina, France, Netherlands, Poland
-
AmgenCompletedOsteogenesis ImperfectaUnited States, Italy, United Kingdom, Belgium, Czechia, Australia, Canada, France, Bulgaria, Poland, Spain, Hungary, Germany
-
Baylor College of MedicineUniversity of California, Los Angeles; Oregon Health and Science University; Hospital... and other collaboratorsRecruiting
-
Clementia Pharmaceuticals Inc.TerminatedExostoses, Multiple HereditaryUnited States, Spain, Canada, Japan, Italy, Portugal, United Kingdom, Turkey, Australia, Belgium, France, Netherlands
-
Ultragenyx Pharmaceutical IncMereo BioPharmaCompletedOsteogenesis Imperfecta Type III | Osteogenesis Imperfecta Type IV | Osteogenesis Imperfecta, Type IUnited States, Canada, Denmark, France, United Kingdom
-
BioMarin PharmaceuticalICON plcCompletedMucopolysaccharidosis IV Type A | Morquio A Syndrome | MPS IVAUnited States, United Kingdom, Australia, Taiwan, Belgium, Malaysia, Austria, Canada, Portugal, France, Ireland, Czechia, Denmark, Italy, Netherlands, Poland, Puerto Rico
-
Bellicum PharmaceuticalsActive, not recruitingStudy of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantLymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Anemia, Aplastic | Primary Immune Deficiency Disorder | Cytopenia | Osteopetrosis | Leukemia, Acute Myeloid (AML), Child | Hemoglobinopathy in ChildrenUnited States